Publications by authors named "David Sternberg"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

83

Total Likes

183

Extended Reach

769,580

Social Features

96
P
Patritumab deruxtecan in HRHER2 advanced breast cancer: a phase 2 trial.
Barbara Pistilli, Fernanda Mosele, Noemie Corcos, Livia Pierotti, Yoann Pradat, David W Sternberg

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.
Thomas Powles, Aarti Bhatia, Barbara Burtness, Takahiro Kogawa, Tomohiro Nishina, David W Sternberg

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy.
Conor E Steuer, Hidetoshi Hayashi, Wu-Chou Su, Makoto Nishio, Melissa L Johnson, David W Sternberg

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd).
Li Li, Mark Lee, Rujuta Joshi, Yuan Xu, Ramon Garcia, David Sternberg

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal Cytology.
Omar Harfouch, Darren Whitfield, Tural Mammadli, Rahwa Eyasu, Connor Volpi, David Sternberg

AIDS Patient Care STDS· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.
Omar Harfouch, Andrea Lisco, Habib Omari, Rahwa Eyasu, Ashley Davis, David Sternberg

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-Associated Genital Immune Biomarkers in the Female Sex Worker Population: A Pilot Study.
Eleanor Capozzi, Jason Daniels, Hani Mohamed, Fernando Cabezas Mejia, David Sternberg

Am J Reprod Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy.
Jyoti Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, David Sternberg

Adv Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced -mutated NSCLC after a third-generation EGFR TKI.
Tony Mok, Pasi A Jänne, Makoto Nishio, Silvia Novello, Martin Reck, David W Sternberg

Future Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Ian E Krop, Norikazu Masuda, Toru Mukohara, Shunji Takahashi, Takahiro Nakayama, David W Sternberg

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic -mutated NSCLC.
Helena A Yu, James Chih-Hsin Yang, Hidetoshi Hayashi, Yasushi Goto, Enriqueta Felip, David W Sternberg

Future Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV.
Kristi C Hill, Sarah M Kattakuzhy, Rachel Silk, Rahwa Eyasu, Onyinyechi Ogbumbadiugha, David Sternberg

Open Forum Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
Kristi Hill, Laura Nussdorf, Julia D Mount, Rachel Silk, Chloe Gross, David Sternberg

J Addict Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.
Christopher Brokus, Sarah Kattakuzhy, Britt Gayle, Shivakumar Narayanan, Ashley Davis, David Sternberg

Open Forum Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, -Mutated Non-Small Cell Lung Cancer.
Pasi A Jänne, Christina Baik, Wu-Chou Su, Melissa L Johnson, Hidetoshi Hayashi, David Sternberg

Cancer Discov· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C.
Ellis Jaewon Yeo, Hannah Kralles, David Sternberg, Dana McCullough, Ajetha Nadanasabesan

Harm Reduct J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
Elana S Rosenthal, Rachel Silk, Poonam Mathur, Chloe Gross, Rahwa Eyasu, David Sternberg

Clin Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parameterization of Fuel-Optimal Synchronous Approach Trajectories to Tumbling Targets.
David Charles Sternberg, David Miller

Front Robot AI· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
Jason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, Cem Akin, Karl Sotlar, David W Sternberg

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can species traits predict the susceptibility of riverine fish to water resource development? An Australian case study.
Robert J Rolls, David Sternberg

Environ Manage· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy.
Cristina Saura, Johanna Bendell, Guy Jerusalem, Shaun Su, Qinhua Ru, David W Sternberg

Clin Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Fred R Hirsch, Fairooz Kabbinavar, Tim Eisen, Renato Martins, Fredrick M Schnell, David W Sternberg

J Clin Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.
Divya Mehra, David I Sternberg, Yuxia Jia, Stephen Canfield, Vincent Lemaitre

Am J Physiol Lung Cell Mol Physiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil and T cell markers predict functional decline in COPD patients.
Jeanine M D'Armiento, Steven M Scharf, Michael D Roth, John E Connett, Andrew Ghio, David Sternberg

Respir Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis